Literature DB >> 22375011

Diabody mixture providing full protection against experimental scorpion envenoming with crude Androctonus australis venom.

Anne di Tommaso1, Matthieu O Juste, Marie-France Martin-Eauclaire, Isabelle Dimier-Poisson, Philippe Billiald, Nicolas Aubrey.   

Abstract

Androctonus australis is primarily involved in envenomations in North Africa, notably in Tunisia and Algeria, and constitutes a significant public health problem in this region. The toxicity of the venom is mainly due to various neurotoxins that belong to two distinct structural and immunological groups, group I (the AahI and AahIII toxins) and group II (AahII). Here, we report the use of a diabody mixture in which the molar ratio matches the characteristics of toxins and polymorphism of the venom. The mixture consists of the Db9C2 diabody (anti-group I) and the Db4C1op diabody (anti-AahII), the latter being modified to facilitate in vitro production and purification. The effectiveness of the antivenom was tested in vivo under conditions simulating scorpion envenomation. The intraperitoneal injection of 30 μg of the diabody mixture protected almost all the mice exposed to 3 LD(50) s.c. of venom. We also show that the presence of both diabodies is necessary for the animals to survive. Our results are the first demonstration of the strong protective power of small quantities of antivenom used in the context of severe envenomation with crude venom.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22375011      PMCID: PMC3340170          DOI: 10.1074/jbc.M112.348912

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  38 in total

1.  [Health program and use of community health workers: the example of scorpion envenomation in Tunisia].

Authors:  M Njah; A Ben Abdelaziz; M Abdouli; M Zaher; A Garaoui
Journal:  Sante       Date:  2001 Jan-Feb

2.  [Fifteen years' experience in scorpion envenomation control in Algeria].

Authors:  A C Benguedda; F Laraba-Djébari; M Ouahdi; H Hellal; L Griene; M Guerenik; Y Laid
Journal:  Bull Soc Pathol Exot       Date:  2002-08

3.  [Delay and characteristics of scorpion bite management in the Sidi-Bouzid region].

Authors:  N Mansour
Journal:  Arch Inst Pasteur Tunis       Date:  2001

4.  Design and evaluation of a diabody to improve protection against a potent scorpion neurotoxin.

Authors:  N Aubrey; C Devaux; P Y Sizaret; H Rochat; M Goyffon; P Billiald
Journal:  Cell Mol Life Sci       Date:  2003-03       Impact factor: 9.261

5.  A strategy for inducing an immune response against Androctonus australis scorpion venom toxin I in mice. Production of high-affinity monoclonal antibodies and their use in a sensitive two-site immunometric assay.

Authors:  Christiane Devaux; Olivier Clot-Faybesse; Martine Pugnière; Jean Claude Mani; Hervé Rochat; Claude Granier
Journal:  J Immunol Methods       Date:  2002-12-20       Impact factor: 2.303

6.  Engineering of a recombinant Fab from a neutralizing IgG directed against scorpion neurotoxin AahI, and functional evaluation versus other antibody fragments.

Authors:  Nicolas Aubrey; Julien Muzard; Jean Christophe Peter; Hervé Rochat; Max Goyffon; Christiane Devaux; Philippe Billiald
Journal:  Toxicon       Date:  2004-03-01       Impact factor: 3.033

7.  Construction and functional evaluation of a single-chain antibody fragment that neutralizes toxin AahI from the venom of the scorpion Androctonus australis hector.

Authors:  C Devaux; E Moreau; M Goyffon; H Rochat; P Billiald
Journal:  Eur J Biochem       Date:  2001-02

Review 8.  Single domain camel antibodies: current status.

Authors:  S Muyldermans
Journal:  J Biotechnol       Date:  2001-06       Impact factor: 3.307

9.  Immunized camel sera and derived immunoglobulin subclasses neutralizing Androctonus australis hector scorpion toxins.

Authors:  Fatma Meddeb-Mouelhi; Balkiss Bouhaouala-Zahar; Zakaria Benlasfar; Mohamed Hammadi; Thouraya Mejri; Mekki Moslah; Habib Karoui; Touhami Khorchani; Mohamed El Ayeb
Journal:  Toxicon       Date:  2003-12       Impact factor: 3.033

10.  Molecular cloning and functional expression of the alpha-scorpion toxin BotIII: pivotal role of the C-terminal region for its interaction with voltage-dependent sodium channels.

Authors:  Khadija Benkhadir; Riadh Kharrat; Sandrine Cestèle; Amor Mosbah; Hervé Rochat; Mohamed El Ayeb; Habib Karoui
Journal:  Peptides       Date:  2004-02       Impact factor: 3.750

View more
  6 in total

1.  Creation of recombinant antigen-binding molecules derived from hybridomas secreting specific antibodies.

Authors:  Conor Fields; David O'Connell; Sujing Xiao; Gil U Lee; Philippe Billiald; Julien Muzard
Journal:  Nat Protoc       Date:  2013-05-16       Impact factor: 13.491

Review 2.  Engineering venom's toxin-neutralizing antibody fragments and its therapeutic potential.

Authors:  Larissa M Alvarenga; Muhammad Zahid; Anne di Tommaso; Matthieu O Juste; Nicolas Aubrey; Philippe Billiald; Julien Muzard
Journal:  Toxins (Basel)       Date:  2014-08-21       Impact factor: 4.546

3.  A method to confer Protein L binding ability to any antibody fragment.

Authors:  Zineb Lakhrif; Martine Pugnière; Corinne Henriquet; Anne di Tommaso; Isabelle Dimier-Poisson; Philippe Billiald; Matthieu O Juste; Nicolas Aubrey
Journal:  MAbs       Date:  2015-12-18       Impact factor: 5.857

4.  Exploration and Modulation of Antibody Fragment Biophysical Properties by Replacing the Framework Region Sequences.

Authors:  Thomas Cnudde; Zineb Lakhrif; Justine Bourgoin; Fanny Boursin; Catherine Horiot; Corinne Henriquet; Anne di Tommaso; Matthieu Olivier Juste; Isabella Gizzi Jiacomini; Isabelle Dimier-Poisson; Martine Pugnière; Marie-Nöelle Mévélec; Nicolas Aubrey
Journal:  Antibodies (Basel)       Date:  2020-04-15

Review 5.  Serotherapy against Voltage-Gated Sodium Channel-Targeting αToxins from Androctonus Scorpion Venom.

Authors:  Marie-France Martin-Eauclaire; Sonia Adi-Bessalem; Djelila Hammoudi-Triki; Fatima Laraba-Djebari; Pierre E Bougis
Journal:  Toxins (Basel)       Date:  2019-01-23       Impact factor: 4.546

Review 6.  Biotechnological Trends in Spider and Scorpion Antivenom Development.

Authors:  Andreas Hougaard Laustsen; Mireia Solà; Emma Christine Jappe; Saioa Oscoz; Line Præst Lauridsen; Mikael Engmark
Journal:  Toxins (Basel)       Date:  2016-07-23       Impact factor: 4.546

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.